UnitedHealth Group Incorporated (TSX:UNH)
Canada · Delayed Price · Currency is CAD 17.16
-0.12 (-0.69%)
Oct 6, 2026, 3:59 PM EST
UnitedHealth Group Ratios and Metrics
Market cap in millions CAD. Fiscal year is January - December.
Millions CAD. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 6, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 480,331 | 410,001 | 669,830 | 643,075 | 670,448 | 598,502 | |
Market Cap Growth | 5.55% | -38.79% | 4.16% | -4.08% | 12.02% | 41.17% |
Enterprise Value | 554,624 | 496,316 | 749,729 | 687,897 | 694,941 | 636,763 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 6, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 23.95 | 24.80 | 32.32 | 21.76 | 24.62 | 27.36 |
PS Ratio | 0.75 | 0.67 | 1.16 | 1.31 | 1.53 | 1.64 |
PB Ratio | 3.19 | 2.94 | 4.54 | 4.92 | 5.74 | 6.18 |
P/FCF Ratio | 14.32 | 18.60 | 22.48 | 18.96 | 21.17 | 23.78 |
P/OCF Ratio | 12.52 | 15.18 | 19.23 | 16.75 | 18.90 | 21.17 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 6, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 0.87 | 0.81 | 1.30 | 1.40 | 1.58 | 1.75 |
EV/EBITDA Ratio | 13.79 | 15.05 | 14.89 | 14.83 | 16.65 | 19.23 |
EV/EBIT Ratio | 16.19 | 16.93 | 16.14 | 16.10 | 18.06 | 20.99 |
EV/FCF Ratio | 16.54 | 22.52 | 25.17 | 20.28 | 21.94 | 25.30 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 6, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.69 | 0.82 | 0.75 | 0.63 | 0.67 | 0.60 |
Debt / EBITDA Ratio | 2.59 | 3.24 | 2.20 | 1.78 | 1.87 | 1.76 |
Debt / FCF Ratio | 3.11 | 5.16 | 3.71 | 2.44 | 2.46 | 2.31 |
Net Debt / Equity Ratio | 0.42 | 0.58 | 0.50 | 0.38 | 0.40 | 0.32 |
Net Debt / EBITDA Ratio | 1.68 | 2.44 | 1.48 | 1.06 | 1.11 | 0.94 |
Net Debt / FCF Ratio | 1.90 | 3.65 | 2.49 | 1.45 | 1.46 | 1.24 |
Quick Ratio | 0.70 | 0.70 | 0.75 | 0.69 | 0.65 | 0.66 |
Current Ratio | 0.78 | 0.79 | 0.83 | 0.75 | 0.73 | 0.73 |
Asset Turnover | 1.46 | 1.47 | 1.40 | 1.43 | 1.42 | 1.41 |
Return on Equity (ROE) | 14.15% | 12.54% | 15.13% | 24.98% | 25.35% | 24.12% |
Return on Assets (ROA) | 4.87% | 4.40% | 7.06% | 7.79% | 7.76% | 7.32% |
Return on Invested Capital (ROIC) | 11.37% | 10.23% | 14.38% | 16.84% | 16.72% | 16.11% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 6, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 4.18% | 4.03% | 3.09% | 4.60% | 4.06% | 3.65% |
FCF Yield | 6.98% | 5.38% | 4.45% | 5.27% | 4.72% | 4.21% |
Dividend Yield | 2.43% | 79.68% | 51.01% | 40.14% | 35.54% | - |
Payout Ratio | 57.33% | 65.66% | 52.29% | 30.21% | 29.78% | 30.55% |
Buyback Yield / Dilution | 1.47% | 1.94% | 0.96% | 1.26% | 0.63% | 0.52% |
Total Shareholder Return | 3.90% | 81.62% | 51.97% | 41.41% | 36.17% | 0.52% |